(Q44397116)

2 December 2017

title

Exacerbated autoimmune hepatitis successfully treated with leukocytapheresis and bilirubin adsorption therapy (English)

1 reference

2 December 2017

1 reference

K Sawada

1

1 reference

2 December 2017

K Ohnishi

2

1 reference

2 December 2017

T Kosaka

3

1 reference

2 December 2017

S Chikano

4

1 reference

2 December 2017

A Egashira

5

1 reference

2 December 2017

M Okui

6

1 reference

2 December 2017

S Shintani

7

1 reference

2 December 2017

M Wada

8

1 reference

2 December 2017

K Nakasho

9

1 reference

2 December 2017

T Shimoyama

10

1 reference

2 December 2017

publication date

1 October 1997

1 reference

Journal of Gastroenterology

2 December 2017

published in

1 reference

2 December 2017

volume

32

1 reference

2 December 2017

issue

5

1 reference

2 December 2017

page(s)

689-695

1 reference

Sustained remission after corticosteroid therapy of severe hepatitis B surface antigen-negative chronic active hepatitis

2 December 2017

cites work

1 reference

12 December 2020

Extrahepatic malignancy following long-term immunosuppressive therapy of severe hepatitis B surface antigen-negative chronic active hepatitis

1 reference

12 December 2020

Preferential activation of helper/inducer T lymphocytes in autoimmune chronic active hepatitis

1 reference

12 December 2020

Oral pulse prednisone therapy in the treatment of HBsAg negative chronic active hepatitis

1 reference

12 December 2020

Effect of Corticosteroids on Suppressor-Cell Activity in Autoimmune and Viral Chronic Active Hepatitis

1 reference

12 December 2020

Does the immune response play a role in the pathogenesis of chronic liver disease?

1 reference

12 December 2020

Characterization of effector cells in lymphocytotoxicity to autologous hepatocytes in HBsAg-positive and autoimmune chronic active hepatitis (CAH)

1 reference

12 December 2020

Cyclosporine treatment of autoimmune chronic active hepatitis

1 reference

12 December 2020

Autoimmune hepatitis: The realities and the uncertainties

1 reference

12 December 2020

Low-dose corticosteroid therapy after multiple relapses of severe HBsAg-negative chronic active hepatitis

1 reference

12 December 2020

Trailmaking and number-connection tests in the assessment of mental state in portal systemic encephalopathy.

1 reference

12 December 2020

Clinical utility of assays for circulating immune complexes.

1 reference

12 December 2020

A human T-cell clone cytotoxic for hepatocytes from patients with chronic non-A, non-B hepatitis

1 reference

12 December 2020

Removal of Limulus test-interfering factors in blood samples with perchloric acid and the improvement of the specificity of the Limulus test by fractionating amebocyte lysate

1 reference

12 December 2020

[A case of autoimmune hepatitis with multinucleated giant hepatocytes]

1 reference

12 December 2020

Pharmacological studies of FUT-175, nafamstat mesilate. I. Inhibition of protease activity in in vitro and in vivo experiments.

1 reference

12 December 2020

Analysis of the in vitro cytokine production by liver-infiltrating T cells of patients with autoimmune hepatitis

1 reference

12 December 2020

Leukocytapheresis therapy, performed with leukocyte removal filter, for inflammatory bowel disease

1 reference

12 December 2020

An enzyme-linked immunosorbent assay for the measurement of human interleukin-6

1 reference

12 December 2020

Autoimmunity and liver disease

1 reference

12 December 2020

Relapse following treatment withdrawal in patients with autoimmune chronic active hepatitis

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02934123

1 reference

2 December 2017

1 reference